Sfoglia per Autore
Remission of low-grade lymphomatoid granulomatosis with extensive pulmonary involvement following immune restoration via antiretroviral therapy in a newly diagnosed HIV patient
2025 Kogan, M; Alviano, A; Catalano, M; Casiraghi, A; Ghilardi, G; Rindone, G; Verga, L; L'Imperio, V; Passerini, C; Bonfanti, P; Lapadula, G; Cocito, F; Soria, A
Pirtobrutinib is an Effective Salvage Treatment After Ibrutinib in Bing–Neel Syndrome
2025 Frustaci, A; Zappaterra, A; Turri, G; Rossi, V; Deodato, M; Gambacorti‐passerini, C; Cairoli, R; Danesi, R; Tedeschi, A
Case Report: Successful use of emapalumab in adult B-cell acute lymphoblastic leukemia experiencing severe neurotoxicity and hemophagocytic lymphohistiocytosis-like features after CAR-T cell therapy
2025 Manghisi, B; Cotilli, G; Fedele, M; Perfetti, P; Terruzzi, E; Verga, L; Borin, L; Carrer, A; Fumagalli, M; Ferrari, M; Moretti, A; Rona, R; Benini, A; Vergnano, B; Palumbo, G; Zincone, A; Maglia, O; Scollo, C; Steidl, C; Iovino, L; Balduzzi, A; Piazza, R; Gambacorti-Passerini, C; Parma, M; Aroldi, A
Hb Monza: A novel extensive HBB duplication with preserved α-β subunit interaction and unstable hemoglobin phenotype
2025 Civettini, I; Zappaterra, A; Corti, P; Messina, A; Aroldi, A; Biondi, A; Cavalca, F; Crippa, V; Crosti, F; Ferrari, G; Malighetti, F; Mologni, L; Piperno, A; Ramazzotti, D; Scollo, C; Zambon, A; Rossi, F; Gambacorti-Passerini, C
Repurposing pexmetinib as an inhibitor of TKI-resistant BCR::ABL1
2024 Fontana, D; Malighetti, F; Villa, M; Zambon, A; Gambacorti-Passerini, C; Mologni, L
Idiopathic erythrocytosis: a germline disease?
2024 Elli, E; Mauri, M; D’Aliberti, D; Crespiatico, I; Fontana, D; Redaelli, S; Pelucchi, S; Spinelli, S; Manghisi, B; Cavalca, F; Aroldi, A; Ripamonti, A; Ferrari, S; Palamini, S; Mottadelli, F; Massimino, L; Ramazzotti, D; Cazzaniga, G; Piperno, A; Gambacorti-Passerini, C; Piazza, R
Advances in the understanding of molecular genetics and therapy ofRichter transformation in chronic lymphocytic leukemia
2024 Deodato, M; Frustaci, A; Zappaterra, A; Rapella, A; Gambacorti-Passerini, C; Cairoli, R; Montillo, M; Tedeschi, A
Anaplastic Lymphoma Kinase (ALK) Inhibitors Enhance Phagocytosis Induced by CD47 Blockade in Sensitive and Resistant ALK-Driven Malignancies
2024 Malighetti, F; Villa, M; Mauri, M; Piane, S; Crippa, V; Crespiatico, I; Cocito, F; Bossi, E; Steidl, C; Civettini, I; Scollo, C; Ramazzotti, D; Gambacorti-Passerini, C; Piazza, R; Mologni, L; Aroldi, A
CNS relapse risk in HIV-positive patients affected by DLBCL and HGBL – a retrospective study of the musthal cohort
2024 Rindone, G; Rossi, M; Sabbatini, F; Columpsi, P; Dalu, D; Fasola, C; Vitiello, P; Viganò, C; Suardi, E; Gambacorti Passerini, C; Bonfanti, P; Bandera, A; Verga, L
miR-15a targets the HSP90 co-chaperone Morgana in chronic myeloid leukemia
2024 Poggio, P; Rocca, S; Fusella, F; Ferretti, R; Ala, U; D'Anna, F; Giugliano, E; Panuzzo, C; Fontana, D; Palumbo, V; Carrà, G; Taverna, D; Gambacorti-Passerini, C; Saglio, G; Fava, C; Piazza, R; Morotti, A; Orso, F; Brancaccio, M
Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma
2024 Villa, M; Geeta, G; Malighetti, F; Mauri, M; Arosio, G; Cordani, N; Lobello, C; Larose, H; Pirola, A; D'Aliberti, D; Massimino, L; Criscuolo, L; Pagani, L; Chinello, C; Mastini, C; Fontana, D; Bombelli, S; Meneveri, R; Lovisa, F; Mussolin, L; Janikova, A; Pospíšilová, Š; Turner, S; Inghirami, G; Magni, F; Urso, M; Pagni, F; Ramazzotti, D; Piazza, R; Chiarle, R; Gambacorti-Passerini, C; Mologni, L
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis
2024 Crespiatico, I; Zaghi, M; Mastini, C; D'Aliberti, D; Mauri, M; Mercado, C; Fontana, D; Spinelli, S; Crippa, V; Inzoli, E; Manghisi, B; Civettini, I; Ramazzotti, D; Sangiorgio, V; Gengotti, M; Brambilla, V; Aroldi, A; Banfi, F; Barone, C; Orsenigo, R; Riera, L; Riminucci, M; Corsi, A; Breccia, M; Morotti, A; Cilloni, D; Roccaro, A; Sacco, A; Stagno, F; Serafini, M; Mottadelli, F; Cazzaniga, G; Pagni, F; Chiarle, R; Azzoni, E; Sessa, A; Gambacorti Passerini, C; Elli, E; Mologni, L; Piazza, R
Evaluating the performance of large language models in haematopoietic stem cell transplantation decision-making
2024 Civettini, I; Zappaterra, A; Granelli, B; Rindone, G; Aroldi, A; Bonfanti, S; Colombo, F; Fedele, M; Grillo, G; Parma, M; Perfetti, P; Terruzzi, E; Gambacorti-Passerini, C; Ramazzotti, D; Cavalca, F
First-Hit SETBP1 Mutations Cause a Myeloproliferative Disorder with Bone Marrow Fibrosis Mimicking Triple Negative Myelofibrosis
2024 Fontana, D; Crespiatico, I; Zaghi, M; Mastini, C; D’Aliberti, D; Mauri, M; Mercado, C; Spinelli, S; Crippa, V; Inzoli, E; Manghisi, B; Civettini, I; Ramazzotti, D; Sangiorgio, V; Gengotti, M; Brambilla, V; Aroldi, A; Banfi, F; Barone, C; Orsenigo, R; Riera, L; Riminucci, M; Corsi, A; Breccia, M; Morotti, A; Cilloni, D; Roccaro, A; Sacco, A; Stagno, F; Serafini, M; Mottadelli, F; Cazzaniga, G; Pagni, F; Chiarle, R; Azzoni, E; Sessa, A; Gambacorti-Passerini, C; Elli, E; Mologni, L; Piazza, R
Late relapse of chronic myeloid leukemia after allogeneic bone marrow transplantation points to KANSARL (KANSL1::ARL17A) alteration: a case report with insights on the molecular landscape
2024 Fontana, D; Zambrotta, G; Scannella, A; Piazza, R; Gambacorti-Passerini, C
Hairy cell leukemia with an atypical extranodal presentation: A clinicopathological analysis of four cases
2024 Sangiorgio, V; Palasciano, A; Tabanelli, V; Giné, E; Guerra, L; Pagni, F; Casiraghi, A; Casaroli, I; Frigola, G; Magnano, L; Gambacorti-Passerini, C; Derenzini, E; Vanazzi, A; Campo, E
Integrating mutational profiles and transcriptional data with ASTUTE to elucidate the key molecular functions involved in the pathogenesis of cancer
2024 Crippa, V; Fontana, D; Civettini, I; Mologni, L; Piazza, R; Gambacorti Passerini, C; Ramazzotti, D
Repurposing pexmetinib as an inhibitor of TKI-resistant BCR::ABL1
2024 Fontana, D; Malighetti, F; Villa, M; Zambon, A; Gambacorti-Passerini, C; Mologni, L
Asciminib in Newly Diagnosed Chronic Myeloid Leukemia
2024 Gambacorti-Passerini, C; Piazza, R
Impact of age and comorbidities on the efficacy and tolerability of bosutinib in previously treated patients with chronic myeloid leukemia: results from the phase 4 BYOND study
2024 Rosti, G; Brummendorf, T; Gjertsen, B; Giraldo-Castellano, P; Castagnetti, F; Gambacorti-Passerini, C; Ernst, T; Zhao, H; Kuttschreuter, L; Purcell, S; Giles, F; Hochhaus, A
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile